health care

Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) Q4 2026 Earnings Call Transcript

● Apr 28, 2026

Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM) Q4 2026 Earnings Call dated Apr. 28, 2026 Corporate Participants: Soumya Chhajed — Investor Relations...

Senores Pharmaceuticals Ltd (SENORES) Q3 2026 Earnings Call Transcript

● Apr 21, 2026

Senores Pharmaceuticals Ltd (NSE: SENORES) Q3 2026 Earnings Call dated Jan. 20, 2026 Corporate Participants: Swapnil Shah — Promoter and...

Sai Life Sciences Limited (SAILIFE) Q3 2026 Earnings Call Transcript

● Apr 8, 2026

Sai Life Sciences Limited (NSE: SAILIFE) Q3 2026 Earnings Call dated Feb. 06, 2026 Corporate Participants: Krishna Kanumuri — Managing...

Inventurus Knowledge Solutions Ltd (IKS) Q3 2026 Earnings Call Transcript

● Apr 6, 2026

Inventurus Knowledge Solutions Ltd (NSE: IKS) Q3 2026 Earnings Call dated Feb. 05, 2026 Corporate Participants: Saransh Mundra — Head...

Indegene Ltd (INDGN) Q3 2026 Earnings Call Transcript

● Apr 6, 2026

Indegene Ltd (NSE: INDGN) Q3 2026 Earnings Call dated Jan. 30, 2026 Corporate Participants: Abhishek Agarwal — Investor Relations Manish...

Anlon Healthcare Ltd (AHCL) Q3 2026 Earnings Call Transcript

● Feb 23, 2026

Anlon Healthcare Ltd (NSE: AHCL) Q3 2026 Earnings Call dated Feb. 19, 2026 Corporate Participants: Unidentified Speaker Mr. Punitkumar R...

Sanjivani Paranteral Ltd (SANJIVIN) Q3 2026 Earnings Call Transcript

● Feb 23, 2026

Sanjivani Paranteral Ltd (NSE: SANJIVIN) Q3 2026 Earnings Call dated Feb. 16, 2026 Corporate Participants: Srivardhan Khemka — Executive Director...

Eris Lifesciences Ltd (ERIS) Q3 2026 Earnings Call Transcript

● Feb 17, 2026

Eris Lifesciences Ltd (NSE: ERIS) Q3 2026 Earnings Call dated Feb. 13, 2026 Corporate Participants: Krishnakumar Vaidyanathan — Executive Director...

Eris Lifesciences Reports Record Quarterly Revenue of ₹807 Crores

● Feb 13, 2026

Eris Lifesciences Limited (NSE: ERIS; BSE: 540596) shares closed 6.36% lower at ₹1,414.65 on Friday despite reporting record quarterly revenues...

Earnings Summary – Cohance Lifesciences Reports Q3 and Nine-Month Revenue and Profit Decline Amid Inventory Normalization

● Feb 12, 2026

Cohance Lifesciences Limited (NSE: COHANCE) is a global contract research, development, and manufacturing organization focused on innovator partnerships. The company...